SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+6.7%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$467M
AUM Growth
+$467M
(+1%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
35.86%
Holding
100
New
18
Increased
16
Reduced
23
Closed
17
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
$10.1M |
| 2 |
Nova
NVMI
|
$8.21M |
| 3 |
SHLT
SHL Telemedicine Ltd American Depositary Shares
SHLT
|
$7.96M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$7.6M |
| 5 |
Day One Biopharmaceuticals
DAWN
|
$6.33M |
Top Sells
| 1 |
Nutrien
NTR
|
$10.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
$8.46M |
| 3 |
Eli Lilly
LLY
|
$7.5M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$7.45M |
| 5 |
Microsoft
MSFT
|
$6.92M |
Sector Composition
| 1 | Healthcare | 78.63% |
| 2 | Technology | 13.25% |
| 3 | Consumer Discretionary | 3.47% |
| 4 | Utilities | 0.8% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sanofi
SNY
$121B
| $28.5M | 4.46% | 529,515 | – | – |
|
2
AstraZeneca
AZN
$248B
| $20.4M | 3.19% | 285,060 | – | – |
|
3
Johnson & Johnson
JNJ
$427B
| $19.8M | 3.1% | 119,831 | – | – |
|
4
Nice
NICE
$8.73B
| $18.1M | 2.82% | 87,482 -28,000 | -24% | -$5.78M |
|
5
Amazon
AMZN
$2.44T
| $16.2M | 2.53% | 124,300 +38,620 | +45% | +$5.03M |
|
6
Syndax Pharmaceuticals
SNDX
$1.41B
| $15.1M | 2.36% | 723,061 +40,000 | +6% | +$837K |
|
7
Merck
MRK
$210B
| $13.9M | 2.17% | 120,600 | – | – |
|
|
8
Microsoft
MSFT
$3.77T
| $11.7M | 1.82% | 34,312 -20,311 | -37% | -$6.92M |
|
|
9
Praxis Precision Medicines
PRAX
$958M
| $10.1M | 1.57% | +8,764,334 | New | +$10.1M |
|
10
Novo Nordisk
NVO
$251B
| $9.15M | 1.43% | 56,540 -15,000 | -21% | -$2.43M |
|
|
PNT
11
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $8.63M | 1.35% | 952,642 | – | – |
|
12
Ultragenyx Pharmaceutical
RARE
$2.89B
| $8.47M | 1.32% | 183,696 | – | – |
|
|
13
Nova
NVMI
$7.74B
| $8.21M | 1.28% | +70,000 | New | +$8.21M |
|
|
SWTX
14
DELISTED
SpringWorks Therapeutics
SWTX
| $8.2M | 1.28% | 312,625 -5,000 | -2% | -$131K |
|
|
SHLT
15
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
| $7.96M | 1.24% | +714,573 | New | +$7.96M |
|
|
16
Teva Pharmaceuticals
TEVA
$21.1B
| $7.91M | 1.23% | 1,050,000 -989,500 | -49% | -$7.45M |
|
|
17
Alnylam Pharmaceuticals
ALNY
$58.5B
| $7.6M | 1.19% | +40,000 | New | +$7.6M |
|
18
Disc Medicine
IRON
$2.07B
| $7.57M | 1.18% | 170,578 -49,435 | -22% | -$2.19M |
|
19
AbbVie
ABBV
$372B
| $7.54M | 1.18% | 56,000 -7,000 | -11% | -$943K |
|
|
20
Eli Lilly
LLY
$657B
| $7.36M | 1.15% | 15,690 -16,000 | -50% | -$7.5M |
|
21
Merus
MRUS
$4.98B
| $7.33M | 1.14% | 278,333 -58,660 | -17% | -$1.54M |
|
22
Immatics
IMTX
$619M
| $7.12M | 1.11% | 617,173 -163,679 | -21% | -$1.89M |
|
23
Mineralys Therapeutics
MLYS
$1.03B
| $6.91M | 1.08% | 405,400 +66,400 | +20% | +$1.13M |
|
24
Palo Alto Networks
PANW
$127B
| $6.9M | 1.08% | 27,000 +7,000 | +35% | +$1.79M |
|
25
Biogen
BIIB
$19.4B
| $6.79M | 1.06% | 23,846 -9,670 | -29% | -$2.75M |
|